{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T01:15:45Z","timestamp":1783559745268,"version":"3.55.0"},"reference-count":68,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82302529"],"award-info":[{"award-number":["82302529"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515012421"],"award-info":[{"award-number":["2023A1515012421"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010256","name":"Guangzhou Municipal Science and Technology Project","doi-asserted-by":"publisher","award":["2025A04J5237"],"award-info":[{"award-number":["2025A04J5237"]}],"id":[{"id":"10.13039\/501100010256","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Tuberculosis (TB), caused by <jats:italic>Mycobacterium tuberculosis<\/jats:italic> (Mtb), remains a global health crisis complicated by immune dysregulation and T cell exhaustion. CD39, an ectonucleotidase generating immunosuppressive adenosine, is implicated in cancer and chronic infections, yet its spatiotemporal role in TB pathogenesis remains unclear.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Multiple publicly available datasets were utilized to evaluate CD39 across TB disease stages, diverse infectious diseases and anti-TB treatment. Diagnostic accuracy was evaluated via ROC curves and combined signature analysis. Immune cell infiltration were analyzed using CIBERSORTx. Cytokine profiles and age-stratified associations were examined. Pathway enrichment analysis was performed by GSEA. Single-cell analysis of non-human primate granulomas assessed CD39\u2019s temporal dynamics, utilizing Monocle 3 for CD39<jats:sup>+<\/jats:sup> T-cell trajectory analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>CD39 was upregulated in active TB patients versus TB infection (TBI) and healthy controls (HC), correlating with older age, disease severity, and distinct expression patterns compared to other respiratory and systemic infections. CD39 demonstrated superior diagnostic accuracy over IFN-\u03b3 in distinguishing TB from TBI\/HC and other respiratory diseases. Combining CD39 with TBX21 or GZMB further improved diagnostic specificity. High CD39 expression correlated with suppressed Th1 and elevated Th2\/Th17\/regulatory cytokines, alongside pronounced neutrophil infiltration. Age-stratified analysis revealed complex age-dependent associations of CD39 expression with various immune cell types. Single-cell analysis revealed declining CD39 transcriptional activity during prolonged infection despite expanded cellular distribution, linked to early T cell maturation followed by broader immunomodulatory shifts. Decreased CD39 expression with anti-TB treatment correlated with improved immune cell balance and resolved T cell exhaustion.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>CD39 is a critical regulator of immune exhaustion and neutrophil-driven inflammation in TB, with diagnostic and therapeutic potential. Targeting CD39 may provide a novel therapeutic strategy for TB.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2025.1601637","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T05:24:22Z","timestamp":1754889862000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["CD39 dynamics in tuberculosis: a potential biomarker of immune dysregulation and T cell exhaustion"],"prefix":"10.3389","volume":"16","author":[{"given":"Ling","family":"Hao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qari Muhammad","family":"Imran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadeem","family":"Ullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,11]]},"reference":[{"key":"B1","volume-title":"Global Tuberculosis Report 2024","year":"2024"},{"key":"B2","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1186\/s12951-023-02156-y","article-title":"Advanced drug delivery and therapeutic strategies for tuberculosis treatment","volume":"21","author":"Nair","year":"2023","journal-title":"J Nanobiotechnol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60410-2","article-title":"Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis","volume":"375","author":"Gandhi","year":"2010","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit790","article-title":"Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials","volume":"58","author":"Mangtani","year":"2014","journal-title":"Clin Infect Dis"},{"key":"B5","volume-title":"Latent TB infection: updated and consolidated guidelines for programmatic management","year":"2018"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20020340","article-title":"The immune escape mechanisms of mycobacterium tuberculosis","volume":"20","author":"Zhai","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2024.102567","article-title":"Tuberculosis and T cells: Impact of T cell diversity in tuberculosis infection","volume":"149","author":"Vats","year":"2024","journal-title":"Tuberculosis (Edinb)"},{"key":"B8","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1146\/annurev-immunol-090222-110914","article-title":"T cell exhaustion","volume":"42","author":"Baessler","year":"2024","journal-title":"Annu Rev Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1080\/1040841X.2016.1185603","article-title":"T-cell exhaustion in tuberculosis: pitfalls and prospects","volume":"43","author":"Khan","year":"2017","journal-title":"Crit Rev Microbiol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.108","article-title":"The diverse functions of the PD1 inhibitory pathway","volume":"18","author":"Sharpe","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1126\/science.1202947","article-title":"Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4","volume":"332","author":"Qureshi","year":"2011","journal-title":"Science"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216381","article-title":"CD155 and its receptors in cancer immune escape and immunotherapy","volume":"573","author":"Zhou","year":"2023","journal-title":"Cancer Lett"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-023-01569-z","article-title":"LAG-3 as the third checkpoint inhibitor","volume":"24","author":"Aggarwal","year":"2023","journal-title":"Nat Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202048747","article-title":"Combined anti-PD-1 and anti-CTLA-4 checkpoint blockade: Treatment of melanoma and immune mechanisms of action","volume":"51","author":"Willsmore","year":"2021","journal-title":"Eur J Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.00793","article-title":"Pembrolizumab or placebo plus etoposide and platinum as first-line therapy for extensive-stage small-cell lung cancer: randomized, double-blind, phase III KEYNOTE-604 study","volume":"38","author":"Rudin","year":"2020","journal-title":"J Clin Oncol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30413-9","article-title":"Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial","volume":"20","author":"Motzer","year":"2019","journal-title":"Lancet Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005490","article-title":"TIM3 Mediates T Cell Exhaustion during Mycobacterium tuberculosis Infection","volume":"12","author":"Jayaraman","year":"2016","journal-title":"PLoS Pathog"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.1.116","article-title":"Programmed death (PD)-1:PD-ligand 1\/PD-ligand 2 pathway inhibits T cell effector functions during human tuberculosis","volume":"181","author":"Jurado","year":"2008","journal-title":"J Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1007394107","article-title":"Programmed death-1 (PD-1)-deficient mice are extraordinarily sensitive to tuberculosis","volume":"107","author":"L\u00e1z\u00e1r-Moln\u00e1r","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abf3861","article-title":"PD-1 blockade exacerbates Mycobacterium tuberculosis infection in rhesus macaques","volume":"6","author":"Kauffman","year":"2021","journal-title":"Sci Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1038\/s41467-020-15025-1","article-title":"TIGIT limits immune pathology during viral infections","volume":"11","author":"Schorer","year":"2020","journal-title":"Nat Commun"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2013.03.005","article-title":"CD39 and CD73 in immunity and inflammation","volume":"19","author":"Antonioli","year":"2013","journal-title":"Trends Mol Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.837230","article-title":"Adenosine-A2A receptor pathway in cancer immunotherapy","volume":"13","author":"Sun","year":"2022","journal-title":"Front Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-14-0018","article-title":"Inhibition of CD39 enzymatic function at the surface of tumor cells alleviates their immunosuppressive activity","volume":"3","author":"Bastid","year":"2015","journal-title":"Cancer Immunol Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-18-0056","article-title":"A2AR antagonism with CPI-444 induces antitumor responses and augments efficacy to anti-PD-(L)1 and anti-CTLA-4 in preclinical models","volume":"6","author":"Willingham","year":"2018","journal-title":"Cancer Immunol Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1308209110","article-title":"Blockade of A2A receptors potently suppresses the metastasis of CD73+ tumors","volume":"110","author":"Beavis","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2009.03908.x","article-title":"Characterization of regulatory T cells identified as CD4(+)CD25(high)CD39(+) in patients with active tuberculosis","volume":"156","author":"Chiacchio","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.tube.2014.07.002","article-title":"Circulating mycobacterial-reactive CD4+ T cells with an immunosuppressive phenotype are higher in active tuberculosis than latent tuberculosis infection","volume":"94","author":"Kim","year":"2014","journal-title":"Tuberculosis (Edinb)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/imm.13493","article-title":"CD39 pathway inhibits Th1 cell function in tuberculosis","volume":"166","author":"Luo","year":"2022","journal-title":"Immunology"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0092340","article-title":"Increased complement C1q level marks active disease in human tuberculosis","volume":"9","author":"Cai","year":"2014","journal-title":"PLoS One"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0026938","article-title":"Functional correlations of pathogenesis-driven gene expression signatures in tuberculosis","volume":"6","author":"Maertzdorf","year":"2011","journal-title":"PLoS One"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiv238","article-title":"Dysregulation of apoptosis is a risk factor for tuberculosis disease progression","volume":"212","author":"Elliott","year":"2015","journal-title":"J Infect Dis"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0162220","article-title":"The transcriptional signature of active tuberculosis reflects symptom status in extra-pulmonary and pulmonary tuberculosis","volume":"11","author":"Blankley","year":"2016","journal-title":"PLoS One"},{"key":"B34","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/s42003-020-01318-0","article-title":"Lung gene expression signatures suggest pathogenic links and molecular markers for pulmonary tuberculosis, adenocarcinoma and sarcoidosis","volume":"3","author":"Chai","year":"2020","journal-title":"Commun Biol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"5028","DOI":"10.1038\/s41467-025-60255-w","article-title":"Unravelling the transcriptome of the human tuberculosis lesion and its clinical implications","volume":"16","author":"Fonseca","year":"2025","journal-title":"Nat Commun"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30928-2","article-title":"Transcriptomic signatures for diagnosing tuberculosis in clinical practice: a prospective, multicentre cohort study","volume":"21","author":"Hoang","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"B37","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1093\/infdis\/jis499","article-title":"Distinct phases of blood gene expression pattern through tuberculosis treatment reflect modulation of the humoral immune response","volume":"207","author":"Cliff","year":"2013","journal-title":"J Infect Dis"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/nature09247","article-title":"An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis","volume":"466","author":"Berry","year":"2010","journal-title":"Nature"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-02-002477","article-title":"Gene expression patterns in blood leukocytes discriminate patients with acute infections","volume":"109","author":"Ramilo","year":"2007","journal-title":"Blood"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13427","article-title":"Predictive model for inflammation grades of chronic hepatitis B: Large-scale analysis of clinical parameters and gene expressions","volume":"37","author":"Zhou","year":"2017","journal-title":"Liver Int"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-044497","article-title":"Prospective validation study of prognostic biomarkers to predict adverse outcomes in patients with COVID-19: a study protocol","volume":"11","author":"Tang","year":"2021","journal-title":"BMJ Open"},{"key":"B42","doi-asserted-by":"publisher","first-page":"22958","DOI":"10.1038\/s41598-021-02489-4","article-title":"Upregulated type I interferon responses in asymptomatic COVID-19 infection are associated with improved clinical outcome","volume":"11","author":"Masood","year":"2021","journal-title":"Sci Rep"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/s41467-021-21289-y","article-title":"Dysregulated transcriptional responses to SARS-CoV-2 in the periphery","volume":"12","author":"McClain","year":"2021","journal-title":"Nat Commun"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02893","article-title":"Human hookworm infection enhances mycobacterial growth inhibition and associates with reduced risk of tuberculosis infection","volume":"9","author":"O\u2019Shea","year":"2018","journal-title":"Front Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0009321","article-title":"Localized skin inflammation during cutaneous leishmaniasis drives a chronic, systemic IFN-\u03b3 signature","volume":"15","author":"Farias Amorim","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"key":"B46","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.immuni.2022.04.004","article-title":"Multimodal profiling of lung granulomas in macaques reveals cellular correlates of tuberculosis control","volume":"55","author":"Gideon","year":"2022","journal-title":"Immunity"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.2859","article-title":"The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells","volume":"32","author":"Trapnell","year":"2014","journal-title":"Nat Biotechnol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.4402","article-title":"Reversed graph embedding resolves complex single-cell trajectories","volume":"14","author":"Qiu","year":"2017","journal-title":"Nat Methods"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2014.09.004","article-title":"Chemokines in tuberculosis: the good, the bad and the ugly","volume":"26","author":"Monin","year":"2014","journal-title":"Semin Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201243262","article-title":"Mycobacterium tuberculosis-specific CD8+ T cells are functionally and phenotypically different between latent infection and active disease","volume":"43","author":"Rozot","year":"2013","journal-title":"Eur J Immunol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201948261","article-title":"Old age-associated enrichment of peripheral T regulatory cells and altered redox status in pulmonary tuberculosis patients","volume":"50","author":"Namdeo","year":"2020","journal-title":"Eur J Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-018-3258-y","article-title":"Recent advances in tuberculosis diagnostics in resource-limited settings","volume":"37","author":"Seki","year":"2018","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00151-8","article-title":"Tuberculosis","volume":"387","author":"Dheda","year":"2016","journal-title":"Lancet"},{"key":"B55","doi-asserted-by":"publisher","first-page":"26884","DOI":"10.1038\/s41598-024-77164-5","article-title":"Specific human gene expression in response to infection is an effective marker for diagnosis of latent and active tuberculosis","volume":"14","author":"Nakiboneka","year":"2024","journal-title":"Sci Rep"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01316-1","article-title":"A blood RNA signature for tuberculosis disease risk: a prospective cohort study","volume":"387","author":"Zak","year":"2016","journal-title":"Lancet"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.3779","article-title":"Assessment of validity of a blood-based 3-gene signature score for progression and diagnosis of tuberculosis, disease severity, and treatment response","volume":"1","author":"Warsinske","year":"2018","journal-title":"JAMA Netw Open"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12249","article-title":"Cytokine and lipid mediator networks in tuberculosis","volume":"264","author":"Mayer-Barber","year":"2015","journal-title":"Immunol Rev"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02350","article-title":"IL-2 restores T-cell dysfunction induced by persistent mycobacterium tuberculosis antigen stimulation","volume":"10","author":"Liu","year":"2019","journal-title":"Front Immunol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2010.10.004","article-title":"IL-17 and Th17 cells in tuberculosis","volume":"21","author":"Torrado","year":"2010","journal-title":"Cytokine Growth Factor Rev"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.983299","article-title":"Role of phagocyte extracellular traps during Mycobacterium tuberculosis infections and tuberculosis disease processes","volume":"14","author":"Garc\u00eda-Bengoa","year":"2023","journal-title":"Front Microbiol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/eji.200425524","article-title":"Adenosine and cAMP are potent inhibitors of the NF-kappa B pathway downstream of immunoreceptors","volume":"35","author":"Minguet","year":"2005","journal-title":"Eur J Immunol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2013.02.009","article-title":"Antibody-mediated immunity against tuberculosis: implications for vaccine development","volume":"13","author":"Achkar","year":"2013","journal-title":"Cell Host Microbe"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0031205","article-title":"Differential macrophage activation alters the expression profile of NTPDase and ecto-5\u2019-nucleotidase","volume":"7","author":"Zanin","year":"2012","journal-title":"PloS One"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2015.07.027","article-title":"CD73 and CD39 ectonucleotidases in T cell differentiation: Beyond immunosuppression","volume":"589","author":"Bono","year":"2015","journal-title":"FEBS Lett"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005177","article-title":"CD39 expression identifies terminally exhausted CD8+ T cells","volume":"11","author":"Gupta","year":"2015","journal-title":"PLoS Pathog"},{"key":"B67","doi-asserted-by":"publisher","first-page":"e0006327","DOI":"10.1371\/journal.pntd.0006327","article-title":"CD39 and immune regulation in a chronic helminth infection: The puzzling case of Mansonella ozzardi","volume":"12","author":"Lima","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"B68","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1186\/s12879-022-07506-z","article-title":"Characterization of multiple soluble immune checkpoints in individuals with different Mycobacterium tuberculosis infection status and dynamic changes during anti-tuberculosis treatment","volume":"22","author":"Chen","year":"2022","journal-title":"BMC Infect Dis"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1601637\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T05:24:23Z","timestamp":1754889863000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1601637\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,11]]},"references-count":68,"alternative-id":["10.3389\/fimmu.2025.1601637"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1601637","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,11]]},"article-number":"1601637"}}